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(57)	 ABSTRACT
Disclosed herein is a method for obtaining a composite inter-
ference-free ultrasound image when non-imaging ultrasound
waves would otherwise interfere with ultrasound imaging. A
conventional ultrasound imaging system is used to collect
frames of ultrasound image data in the presence of non-
imaging ultrasound waves, such as high-intensity focused
ultrasound (HIFU). The frames are directed to a processor
that analyzes the frames to identify portions of the frame that
are interference-free. Interference-free portions of a plurality
of different ultrasound image frames are combined to gener-
ate a single composite interference-free ultrasound image that
is displayed to a user. In this approach, a frequency of the
non-imaging ultrasound waves is offset relative to a fre-
quency of the ultrasound imaging waves, such that the inter-
ference introduced by the non-imaging ultrasound waves
appears in a different portion of the frames.
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INTERFERENCE-FREE ULTRASOUND	 pletely overwhelm the lower energy imaging ultrasound
IMAGING DURING HIFU THERAPY, USING 	 waves produced by the imaging transducer, and any ultra-
SOFTWARE TOOLS
	
	
sonic image generated is saturated with noise caused by the
HIFU wave from the therapeutic transducer.
RELATED APPLICATIONS 	 5	 FIG. 1A schematically illustrates a prior art ultrasound
image 10 in which a scanned field 12 is completely obscured
This application is based on a prior copending provisional
	
by noise 14, caused by the simultaneous operation of an
application, Ser. No. 60/610,456, filed on Sep. 16, 2004, the	 ultrasound imaging pulse (i.e., an ultrasound imaging wave)
benefit of the filing date of which is hereby claimed under 35	 and a HIFU wave (neither shown). In ultrasound image 10, a
U.S.C. §I19(e).	 io clinician may be attempting to focus the HIFU wave on a
treatment site 18. However, because noise 14 completely
GOVERNMENT RIGHTS	 saturates scanned field 12, it is impossible to accurately focus
the HIFU wave onto treatment site 18. If the therapy trans-
This invention was made with U.S. Government support 	 duceris completely de-energized, noise 14 is eliminated from
under grant No. NGT5-40084/US#67-0242 awarded by 15 the scanned field. However, under these conditions, the focal
NASA, under grant No. DAMD17-02-0014 awarded by the	 point of the HIFU wave will not be seen, and thus, the HIFU
U.S. Army MRMC through the University of Mississippi 	 wave cannot be accurately focused on treatment site 18.
NCPA, and under grant No. BES-002932 awarded by the	 While some change in echogenicity at the HIFU focal point
National Science Foundation. The U.S. Government has cer- 	 may persist for a time even after the HIFU wave is no longer
tain rights in the invention.
	
	 20 active, any change in a position of the therapy transducer (or
treatment site 18) will not register until the therapeutic trans-
BACKGROUND
	
	
ducer is re-energized. Thus, the HIFU wave cannot be
focused in real time.
Acoustic therapies include shock wave lithotripsy (SWL),	 Some prior art systems have included a targeting icon in an
high intensity focused ultrasound (HIFU), and ultrasound- 25 ultrasound image to indicate where the known focal point of
enhanced drug delivery. HIFU is used for many therapeutic 	 a specific HIFU transducer would be located in a scanned
applications, including hemostasis, tumor treatment, and tis- 	 image. While this icon may be helpful in determining a posi-
sue necrosis. These procedures are made possible by the 	 tion of the focal region of the HIFU transducer relative to the
unique ability of such acoustic therapy technologies to selec- 	 scanned ultrasound image, such an icon-based technique
tively apply relatively large amounts of therapeutic energy 3o does not enable a clinician to observe real-time results. Once
(on the order of 1000 W/cm 2) to a treatment volume disposed 	 the HIFU therapeutic transducer is energized, the scanned
deep within a body mass, without adversely affecting tissue 	 ultrasound image is completely saturated with noise, and the
disposed between an acoustic therapy transducer that pro- 	 clinician cannot monitor the progress of the treatment without
duces the energy and the treatment volume. HIFU, in particu- 	 again de-energizing the HIFU therapeutic transducer. Fur-
lar, is a powerful medical technique with great potential and is 35 thermore, it should be noted that the accuracy of such icon-
currently being employed, both in the United States and 	 based targeting systems generally degrades during treatment
abroad, to treat tumors. However, to safely implement non-	 due to changes in refraction, temperature of the tissue, the
invasive, HIFU-based transcutaneous acoustic surgery, a 	 presence of bubbles in or near the target area, and patient
medical imaging modality must be used to visualize the inter- 	 movement (including movement associated with respiration).
nal treatment site, for targeting the site and monitoring the 40	 FIG. 1B schematically illustrates a prior art technique dis-
treatment process. Ultrasound imaging is an attractive modal- 	 closed in U.S. Pat. No. 6,425,867 (the disclosure, specifica-
ity for the following reasons: (a) images are available in 	 tion, and drawings of which are hereby specifically incorpo-
real-time; (b) portable imagers are commercially available; 	 rated herein by reference) for reducing the amount of noise
(c) Doppler-based imaging modalities can be used to detect	 disrupting an ultrasound image during HIFU therapy. In FIG.
bleeding; (d) ultrasound imaging is a relatively ubiquitous 45 113, the HIFU wave generated by the therapeutic transducer
medical technology that is commonly available in medical	 has been pulsed. This technique produces an ultrasound
facilities; and, (e) ultrasound imaging is relatively inexpen- 	 image 20, in which the location of noise 24 in a scanned field
sive, compared to other medical imaging systems, such as 	 22 is a function of the interference between the pulsed HIFU
magnetic resonance imaging (MRI). 	 wave generated by the therapy transducer and the ultrasonic
A problem with combining HIFU therapy with ultrasound 50 imaging pulses generated by the scanning transducer. In FIG.
imaging is that the high energy therapeutic waves introduces	 113, noise 24 substantially masks a treatment site 28. This
a significant amount of noise into an ultrasound imaging 	 result would not occur in all cases, because to an observer,
signal employed to monitor the treatment site, making simul-	 noise 24 would move across scanned field 22 as the interfer-
taneous imaging and treatment difficult. Indeed, the high	 ence between the HIFU waves and the imaging pulses varies
energy of the HIFU wave can completely overwhelm conven- 55 in time. Pulsing of the HIFU wave alone would thus enable
tional ultrasonic imaging systems. One analogy that might 	 the clinician to view a noise-free image of the treatment site
help to make this problem clear relates to relative intensities 	 only when noise 24 was randomly shifted to a different part of
of light. Consider the light coming from a star in the evening	 scanned field 22, away from the treatment site. However, such
sky to be analogous to the low power imaging ultrasound	 pulsing alone generates an image that is extremely distracting
waves that are reflected from a target area toward the imaging 60 to a clinician, because noise 24 flickers across scanned field
transducer, while the light from the sun is analogous to the 	 22, making it difficult to concentrate and difficult to consis-
HIFU waves generated by the therapy transducer. When the 	 tently determine where the focal point of the HIFU wave is,
sun is out, the light from the stars is completely overwhelmed 	 relative to the treatment site, in real time.
by the light from the sun, and a person looking into the sky is 	 FIG. 1C schematically illustrates another prior art tech-
unable to see any stars, because the bright light from the sun 65 pique that is disclosed in U.S. Pat. No. 6,425,867 (referred to
completely masks the dim light coming from the stars. Simi-	 hereafter as the '867 patent), also for reducing the amount of
larly, the HIFU waves emitted by the therapy transducer com- 	 noise disrupting an ultrasound image during HIFU therapy. In
US 7,670,291 B2
3
	
4
an ultrasound image 30, a HIFU wave from a therapy trans-
ducer has been both pulsed and synchronized with respect to
the ultrasonic imaging pulses from an imaging transducer, to
ensure that noise 34 does not obscure a treatment site 38. In
ultrasound image 30, noise 34 has been shifted to a location
within a scanned field 32 that is spaced apart from treatment
site 38, by selectively adjusting both the pulsing and the
synchronization of the HIFU wave. Preferably, noise 34 is
shifted completely away from treatment site 38, thus provid-
ing the clinician a noise-free, stable image of treatment site 38
that clearly shows the location of the focal point of the HIFU
wave relative to the treatment site. Thus, the HIFU wave can
be focused onto treatment site 38, in real time. By synchro-
nizing the HIFU bursts within each imaging frame, the inter-
ference can be relegated to certain portions of the image, such
as a fringe of the ultrasound image, enabling other portions of
the ultrasound image to remain useful for monitoring and
guidance. If the imaging process and the HIFU bursts are not
synchronized, the interference will randomly obscure the
treatment site, generally as indicated in the example of FIG.
1B.
FIG. 2 is a block diagram from the '867 patent, schemati-
cally illustrating a system that synchronizes the ultrasound
image and HIFU waves required for the simultaneous imag-
ing and therapy in real time. A conventional imaging probe 44
is connected to an ultrasound imaging machine 40 via a cable
42. Imaging probe 44 generates ultrasonic imaging pulses
that propagate to the target area, are reflected from structure
and tissue within the body, and are received by the imaging
probe. The signal produced by the imaging probe in response
to the reflected ultrasound imaging waves is communicated to
the ultrasound imaging machine through cable 42 and pro-
cessed to provide a visual representation of the structure and
tissue that reflected the ultrasonic imaging pulses. An imag-
ing beam sector 46 from imaging probe 44 is identified in the
Figure by dash lines. The system described in the '867 patent
also includes a therapeutic transducer 60. When excited, this
therapeutic transducer generates HIFU waves that are
focused at a particular point of interest, i.e., a treatment site
within a patient's body. In FIG. 2, the path of a HIFU beam 62
(indicated by solid lines to the right of therapeutic transducer
60) narrows to a focal point 64.
Synchronization output signal 48 is supplied to a synchro-
nization delay 50, which enables the user to selectively vary
the initiation of each HIFU wave with respect to each
sequence of ultrasonic imaging pulses that are generated to
form an ultrasonic image. Referring to FIG. 1C, delay 50
enables a user to vary the position of noise 34 in scanned field
32, so that the noise is moved away from treatment site 38, to
a different portion of scanned field 32. A HIFU duration
circuit 52 is used to control the duration of the HIFU wave. A
longer duration HIFU wave will apply more energy to the
treatment site. If the duration of the HIFU wave is too long,
the duration of noise 34 as shown in ultrasound image 30 will
increase and can extend into the next ultrasound imaging
pulse to obscure treatment site 38, or may completely obscure
ultrasound image 30, generating a display similar to ultra-
sound image 10 in FIG. 1A. Thus, the user will have to
selectively (i.e., manually) adjust HIFU duration circuit 52 to
obtain a noise-free image of treatment site 38, while provid-
ing a sufficient level of energy to the treatment site to achieve
the desired therapeutic effect in an acceptable time. A HIFU
excitation frequency generator 56 is used to generate the
desired frequency for the HIFU wave, and a power amplifier
58 is used to amplify the signal produced by the HIFU exci-
tation frequency generator to achieve the desired energy level
of the HIFU wave. Power amplifier 58 is thus adjustable to
obtain a desired energy level for the HIFU wave.
Significantly, the system disclosed in the '867 patent
requires modifying a conventional ultrasound imaging
5 machine to achieve modified ultrasound imaging machine 40,
which is capable of providing synchronization output signal
48. The '867 patent notes that such a synchronization output
signal is not normally provided in prior art conventional ultra-
sound imaging machines. The '867 patent suggests that if an
io ultrasound imaging machine capable of providing the syn-
chronization output signal is not available, then a synchroni-
zation output signal can be derived from the ultrasound imag-
ing signals conveyed by cable 42. The '867 patent also
suggests that an optional stable synchronization signal gen-
15 erator 66 can be used to synchronize the HIFU wave to the
imaging ultrasonic wave, instead of using synchronization
output signal 48 from ultrasound imaging machine 40. Stable
synchronization signal generator 66 can be used to provide a
stable synchronizing pulse to initiate the HIFU wave, and the
20 timing of this stable synchronizing pulse can be manually
varied until a noise-free image of the treatment site has been
obtained.
Essentially, the '867 patent addresses HIFU interference of
ultrasound imaging by synchronizing the interference so that
25 the interference is stable and is located at the fringes of the
image. As a result, the region of interest in the image is not
obscured (like the condition that is schematically indicated in
FIG. 1Q. This functionality requires knowledge of the frame
rate and phase of the imaging cycle, both of which vary with
30 changes to user control settings (particularly depth and
switching modality from b-mode to Doppler). Once the frame
rate and phase are known, HIFU can be gated synchronously
with the imaging cycle and the interference that is caused can
be moved to the fringes of the image. Unfortunately, there is
35 no simple way of determining the frame rate and phase of a
stand-alone commercial imager that has not been designed to
provide such information (i.e., which has not been modified
to provide synchronization output signal 48).
As indicated in the '867 patent, ultrasound imaging sys-
40 tems can be designed to incorporate a synchronization output
signal. However, even though ultrasound imaging systems
are significantly less expensive than MRI imaging systems,
high end ultrasound imaging systems can still cost in excess
of $150,000, and it would be desirable to provide a synchro-
45 nization technique that is compatible with ultrasound imag-
ing systems that do not provide a synchronization output
signal (the majority of ultrasound imaging systems sold do
not provide any signal corresponding to the synchronization
output signal described in the '867 patent). The '867 patent
5o also suggests that the synchronization signal (frame rate with-
out phase information) could be obtained from the cable
coupling an ultrasound imaging probe to ultrasound imaging
machines. This theoretically could be achieved by detecting
current in the cable. However, such cables include many wires
55 conducting various different electrical currents, and these
cables are well shielded to meet safety and radio frequency
interference standards. Hence, obtaining the signal necessary
for synchronization from a shielded cable is generally a chal-
lenging task. The cable could be modified to facilitate extrac-
60 tion of the synchronization signal; however, such a modifica-
tion is not likely to be supported by the manufacturers of the
ultrasound imaging equipment, and operators of medical
equipment are unlikely to pursue a modification not sanc-
tionedby a manufacturer, particularly because of the potential
65 liability and loss of warranty concerns. Furthermore, both the
use of synchronization signal generator 66 and synchroniza-
tion output signal 48 simply shift the interference generated
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by the HIFU waves from one portion of the ultrasound image
to another. While this shift does enable a region of interest in
the image to be interference-free, the interference still exists
in other portions of the image displayed to the user.
Thus, it would be desirable to provide a technique for
achieving an interference-free ultrasound image in the pres-
ence of non-imaging ultrasound waves, such as HIFU. It
would further be desirable that such an interference-free
ultrasound image be achievable without modifying a conven-
tional ultrasound imaging apparatus to provide a synchroni-
zation signal.
SUMMARY
Disclosed herein is a technique for using image-processing
software to manipulate data obtained from an ultrasound
imaging system to remove noise generated by non-ultrasound
imaging ultrasound sources, such as a HIFU therapy trans-
ducer. This image processing technique does not require
modification of the ultrasound imaging system and enables a
therapeutic ultrasound transducer to be energized for longer
periods of time, thereby reducing the overall treatment time
required. Rather than using a synchronization signal that is
obtained from the ultrasound imaging system to control the
therapeutic ultrasound transducer, the therapeutic ultrasound
transducer is simply controlled to ensure that the frequency of
the therapy waves are different than a frequency of imaging
waves. This difference in frequencies is used to achieve an
image, as discussed above with respect to FIG. 113, where the
interference moves across the ultrasound image over time.
However, as disclosed herein, unlike the previous approach,
further processing of the ultrasound image occurs before it is
displayed to a user, such that the interference flickering across
the image as in FIG. 1B is eliminated from the image dis-
played to the user.
In this new approach, ultrasound image frames captured by
an ultrasound imaging system are sent to a processor before
being displayed to the user. The processor is configured to
analyze each frame to identify interference-free portions of
the frame. The interference-free portions of the frames are
saved, and combined with other interference-free portions of
other frames until a composite interference-free ultrasound
image can be displayed to the user. This method will have the
effect of reducing a frame rate that can be displayed to user;
however, empirical testing has indicated that a useful, inter-
ference-free ultrasound image, at an acceptable frame rate,
can be obtained under a variety of operating conditions.
In one embodiment, both the ultrasound imaging system
and the therapeutic ultrasound transducer are triggered from
a common external trigger (the common external trigger pref-
erably being implemented using a function generator and a
set of pulse generators). The external trigger can be controlled
such that the interference from the therapeutic ultrasound
transducer sweeps across the ultrasound imaging frames,
generally as indicated in FIG. 113, as discussed above.
In another embodiment, the ultrasound imaging system is
triggered independently, and the frequency of the square
wave used to induce a HIFU duty cycle is varied until the
interference from the HIFU sweeps across the ultrasound
imaging frames, generally as indicated in FIG. 1B.
The processor analyzes each ultrasound image frame by
separating the frame into a plurality of slices. For each slice,
a region of interest is selected from the slice for further
analysis. Preferably, about 10% of the slice is selected for
further analysis, and more preferably, the region of interest
selected comes from a lower portion of the slice, where inter-
ference is most likely to occur. Statistical values for pixel
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intensities are calculated for the region of interest. Based on
the statistical values, a determination is made as to whether
the region of interest includes interference, or is interference-
free. Note that pixel intensity values for interference can be
s readily distinguished from pixel intensity values from a nor-
mal image that is free of interference, because of the relatively
uniformly high pixel intensity values associated with inter-
ference. Based on this analysis, interference-free slices are
saved, and slices including interference are discarded. A plu-
io rality of frames are processed until a composite interference-
free ultrasound image can be obtained.
Preferably, once a slice is saved, the processor discards any
slices corresponding to the same region, until an entire inter-
ference-free image is obtained; the algorithm then starts over,
15 to generate another composite interference-free ultrasound
image. This prevents the same slice from being introduced
more than once into the composite images, which would
produce inaccurately bright pixels. In some embodiments, a
signal is sent to the ultrasound imaging system such that the
20 ultrasound imaging system does not further interrogate
regions for which a slice has been saved.
This Summary has been provided to introduce a few con-
cepts in a simplified form that are further described in detail
below in the Description. However, this Summary is not
25 intended to identify key or essential features of the claimed
subject matter, nor is it intended to be used as an aid in
determining the scope of the claimed subject matter.
DRAWINGS
30
Various aspects and attendant advantages of one or more
exemplary embodiments and modifications thereto will
become more readily appreciated as the same becomes better
understoodby reference to the following detailed description,
35 when taken in conjunction with the accompanying drawings,
wherein:
FIGS. 1A-1C (all Prior Art) respectively illustrate ultra-
sonic images generated during the simultaneous use of ultra-
sound for imaging and therapy, the pulsing of the HIFU in a
4o conventional scanned image, and the synchronized pulsing of
the HIFU and the scan image so as to shift the noise away
from a displayed treatment site;
FIG. 2 (Prior Art) is a block diagram illustrating the com-
45 
ponents of an earlier system that is capable of synchronizing
HIFU therapy in ultrasound imaging, which requires the
modification of commercially available ultrasound imaging
equipment to achieve a synchronization signal;
FIG. 3A is a high level flowchart of an exemplary technique
50 for generating a composite interference-free ultrasoundimage when non-imaging ultrasound waves (such as HIFU)
are present;
FIG. 3B graphically illustrates how three ultrasound
images including interference can be combined to achieve a
55 single composite interference-free ultrasound image;
FIG. 4A (Prior Art) schematically illustrates how an earlier
system for synchronizing HIFU therapy with ultrasound
imaging synchronized the HIFU waves and ultrasound imag-
ing waves such that the interference due to the HIFU waves
60 consistently appeared in the same position in each ultrasound
image frame;
FIG. 4B schematically illustrates how the technique
described herein ensures that the non-imaging ultrasound
waves (e.g., HIFU) and ultrasound imaging waves are offset,
65 such that the interference due to the non-imaging ultrasound
waves does not appear in the same position in each ultrasound
image frame;
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FIG. 4C schematically illustrates how a noise-free portion 	 region of interest), and the overall treatment time is longer
of an ultrasound image shifts across a plurality of frames, and 	 than it would be without such synchronization, because the
how a region of interest in the ultrasound frames can be	 therapy is intermittent (with typical duty cycles of 50-70%).
narrowed to achieve a higher frame rate;	 An additional drawback, discussed above, is that a modifica-
FIG. 5A is a block diagram illustrating a system for gen- 5 tion of the imaging system hardware is typically required to
erating a composite interference-free ultrasound image from 	 obtain the synchronization trigger. The method disclosed
a plurality of ultrasound images that include both interference 	 herein is a software-based technique for obtaining an inter-
and interference-free portions;	 ference-free ultrasound image in the presence of HIFU (or
FIG. 5B schematically illustrates an exemplary computing 	 other non-imaging ultrasound waves), by combining multiple
system used to implement the method of FIG. 3A; 	 io interference-free regions from a plurality of ultrasound
FIG. 6 is a more detailed flowchart of the steps used to 	 images using image processing, thus providing an enhanced
implement the technique of FIG. 3A, for generating a com- 	 field of view for imaging a treatment site. The enhanced field
posite interference-free ultrasound image when non-imaging 	 of view can potentially enable monitoring of undesired thera-
ultrasound waves (such as HIFU) are present; 	 peutic effects away from the treatment site, e.g., due to the
FIG. 7 schematically illustrates how the slicing step of the 15 presence of bone or air interfaces. Note that because the
FIG. 6 can be implemented; 	 synchronization technique discussed above in detail obscures
FIG. 8 is an image of an exemplary user interface that can	 at least part of the image, such undesirable effects can remain
be employed to implement the method of FIG. 3A;	 unobserved using the prior synchronization technique (i.e.,
FIGS. 9A-9C are enlarged images of selected portions of 	 evidence of such undesirable effects can be obscured by the
the exemplary user interface of FIG. 8; 	 20 interference). The techniques disclosed herein can also allow
FIG. 10A schematically illustrates an exemplary HIFU 	 better real-time monitoring of lesion migration outside the
therapy probe including a phased array transducer that can be 	 intended treatment site. An additional advantage provided by
controlled using the user interface of FIG. 8; 	 the present technique is that a requirement for hardwired
FIG. lOBB illustrates additional details for the structure of	 synchronization between the therapy and imaging systems is
the phased array transducer of FIG. 10A.
	
	 25 avoided.Yet another advantage of the present technique is that
the HIFU duty cycle can be increased without sacrificing the
DESCRIPTION
	
	
field of view of the treatment site, thus reducing the overall
treatment time, especially for large treatment volumes.
Figures and Disclosed Embodiments are not 	 FIG. 3A is a high level flowchart of an exemplary technique
Limiting
	
	 30 for generating a composite interference-free ultrasound
image when non-imaging ultrasound waves (such as HIFU)
Exemplary embodiments are illustrated in referenced Fig- 	 are present. In a step 70, ultrasound image data are obtained
ures of the drawings. It is intended that the embodiments and 	 contemporaneously with HIFU therapy, or some other form
Figures disclosed herein are to be considered illustrative 	 of non-imaging ultrasound. While the techniques disclose
rather than restrictive.	 35 herein are particularly well-suited to simultaneous ultrasound
The terms "therapeutic transducer," "HIFU transducer,"	 imaging and HIFU therapy, it should be recognized that such
and "high intensity transducer," as used herein and in the 	 techniques can also be used to achieve an interference-free
claims that follow all refer to a transducer that is capable of 	 composite image in the presence of other types of non-imag-
being energized to produce ultrasonic waves that are much 	 ing ultrasound waves that would otherwise at least partially
more energetic than the ultrasonic waves produced by an 40 interfere with a view of a site. In a step 72, the raw ultrasound
imaging transducer, and which can be focused or directed 	 images (i.e., a plurality of ultrasound image frames) are pro-
onto a discrete location, such as a treatment site in a target 	 cessed to obtain an interference-free composite image. In this
area. The term "HIFU beam" should be understood to refer to 	 step, interference-free portions are selected from a plurality
a characteristic pattern of HIFU waves emitted from a HIFU	 of image frames and are combined to achieve the composite
transducer. Ultrasound is a wave-based phenomenon; how- 45 image. In a step 74, the interference-free composite image is
ever, those of ordinary skill in the art often refer to HIFU 	 displayed.
waves as a "beam," much in the way the science of optics 	 FIG. 3B graphically illustrates how three ultrasound
refers to light as a beam, even though light exhibits aspects of 	 images including both interference-free portions and interfer-
both waves and particles. This dual nature is particularly true 	 ence can be processed to achieve a single composite interfer-
with respect to HIFU waves, because HIFU waves can be 50 ence-free ultrasound image. An ultrasound image frame 76a
focused in much the same way that light can be focused (i.e., 	 includes an interference-free portion 77a. An ultrasound
a focal point of a lens or phased array is associated with HIFU 	 image frame 76b includes an interference-free portion 77b.
waves, and the focal point corresponds to a region where the 	 An ultrasound image frame 76c includes interference-free
HIFU waves are focused so that they are able to deliver a 	 portions 77c and 77d. Image processing techniques can be
maximum amount of acoustic energy). 	 55 used to combine interference-free portions 77a-77d to
As explained above, a major challenge in real-time ultra-	 achieve a composite interference-free image 78. Note that the
sound guidance and monitoring of HIFU therapy is the inter- 	 entire imaging field of view can be reconstructed by overlap-
ference of the HIFU signal with the imaging system. Previ- 	 ping an integer number (k) of scanning windows if the rep-
ously, simultaneous imaging and therapy has been performed	 etition period of the HIFU signal matches the duration of each
by synchronizing bursts of therapy signals with the imaging 60 imaging frame and if the "HIFU on time" is an integer mul-
signals by using a trigger from the imaging system to limit the 	 tiple (k) of the HIFU off time. Compare composite image 78
interference region to an area of the image outside the treat-	 to FIG. 1C, and it will be evident that the entire field of view
ment site (as discussed above with respect to FIGS. 1A, 113, 	 is clearly visible in composite image 78, while a portion of the
1C, and 2). A drawback of such an approach is that the 	 field of view in FIG. 1C is still obscured, despite the synchro-
imaging field of view is limited (i.e., at least some portion of 65 nization described in the '867 patent.
the image is obscured by interference, even though the inter- 	 FIG. 4A (Prior Art) schematically illustrates how an earlier
ference can be shifted away from a particularly important 	 system for synchronizing HIFU therapy with ultrasound
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imaging (i.e., as described in the '867 patent) synchronized 	 composite image. Based on the initial imaging frame rate of
HIFU signals 82a and ultrasound imaging signals 80a, such 	 54 frames per second, and that the combining of 5 frames to
that interference 84a due to the HIFU consistently appeared 	 achieve an interference-free composite image, the overall
in the same position in each ultrasound image frame.	 frame rate is reduced to 11 frames per second.
FIG. 4B schematically illustrates how the technique 5	 As discussed above, one advantage of the present tech-
described herein ensures that HIFU signal 82b andultrasound 	 nique is that the duty cycle of the HIFU therapy can be
imaging signals 80b are offset, such that interference 80b due 	 increased over that which can be obtained using the synchro-
to the HIFU does not appear in the same position in each	 nization techniques disclosed in the '867 patent. The empiri-
ultrasound image frame. The result of the frequency offset is 	 cal study noted above also examined the potential benefits of
that a band of HIFU-induced interference will sweep across io increased duty cycles. On average, when the duty cycle was
the ultrasound image at a rate corresponding to the difference 	 increased from 50% to 95%, the length of lesions produced by
between the frequency of the ultrasound waves and the fre- 	 the HIFU increased by 79%, lesion width increased by 47%,
quency of the HIFU waves. This offset can be achieved in a 	 and lesion volume increased by 342%. Clearly, increased
number of different ways. In one embodiment, both the ultra- 	 duty cycles are beneficial. This study further provided empiri-
sound imaging system and the therapeutic ultrasound trans-  15 cal evidence that lesion volume can be increased by 160%
ducer are triggered from a common external trigger (the com-	 when the HIFU duration it is increased from 3 to 7 seconds
mon external trigger preferably being implemented using a	 with a 90% duty cycle. Thus, the techniques described herein
function generator and a set of pulse generators). The external 	 enable faster real-time image guided HIFU therapy to be
trigger can be controlled such that the interference from the 	 achieved, as compared to previous real-time image guided
therapeutic ultrasound transducer sweeps across the ultra-  20 HIFU therapy techniques.
sound imaging frames, generally as indicated in FIG. 1B 	 The empirical study further indicates that representative
above. In another embodiment, the ultrasound imaging sys-	 lesion shapes differ for different HIFU duty cycles. HIFU
tem is triggered independently, and the frequency of the 	 lesions were usually "tadpole shaped" for relatively lower
square wave used to induce a HIFU duty cycle is varied until
	
duty cycles and were more irregular in shape for relatively
the interference from the HIFU sweeps across the ultrasound 25 higher duty cycles. Such differences can be attributed to a
imaging frames, generally as indicated in FIG. 1B above.	 higher likelihood of cavitational effects at higher duty cycles.
It should be noted that the present technique will reduce the 	 Visible "pits" indicative of cavitation-based mechanical tis-
frame rate of the ultrasound images that are ultimately dis- 	 sue damage were observed near the center of the lesion gen-
played to user. This reduction in frame rate occurs because a 	 erated using a 90% duty cycle.
plurality of frames, which might ordinarily be immediately 30	 Significantly, the empirical study indicates that higher duty
displayed to a user, are combined to achieve a single interfer- 	 cycles introduce more interference into the ultrasound
ence-free composite frame. For example, if three frames with
	
images, and therefore require more raw ultrasound images to
interference must be combined to produce an interference- 	 be combined to achieve a single interference-free composite
free composite frame, the effective frame rate will be about 1/3	 image. Logically, the overall frame rate of the composite
of the actual rate at which frames are generated. This 35 image decreases proportionally to an increase in the number
approach thus inherently will reduce the frame rate of the 	 of overlaps used to create the composite image. For example,
composite images displayed to a user. Significantly, empirical 	 using 10 overlaps for a 91% duty cycle causes a 10-fold
studies have shown that composite interference-free B-mode 	 reduction in the effective frame rate. The composite image
ultrasound images of HIFU therapy can be obtained using	 frame rate can be increased by restricting the sliding windows
commercial imaging systems, with a HIFU therapy system 40 to a region of interest (ROI) in the entire frame, as shown in
energized using an 83% duty cycle, by combining 5 image 	 FIG. 4C. A plurality of ultrasound image frames 86 are col-
frames to remove the HIFU interference in the entire field of
	
lected such that imaging is restricted to a narrow ROI 88; the
view, with an overall frame rate of 11 frames per second. A 	 interference-free portions 90 are thus restricted to the narrow
frame rate of 11 frames per second, particularly where those 	 ROI of each frame. Using this technique, a duty cycle of 91 %
frames are interference-free, is quite acceptable. In the 45 can be achieved with five overlaps and a 50% ROI with only
empirical study, the therapy system included a 3.23-MHz 	 a five-fold reduction in the flame rate.
HIFU transducer (Sonic Concepts, Woodinville, Wash.), 	 FIG. 5A is a block diagram illustrating a system 92 for
driven by a linear amplifier through an electrical matching 	 generating a composite interference-free ultrasound image
circuit. The imaging system was an EUB 6000 ultrasound	 from a plurality of ultrasound images that include both inter-
scanner (Hitachi Medical Systems America, Twinsburg, 50 ference and interference-free portions. System 92 includes a
Ohio), with a 7.5-MHz linear transducer. The imaging and	 HIFU transducer 94, a HIFU driving system 104, an ultra-
therapy systems were synchronized with an external trigger	 sound imaging probe 98, an ultrasound imaging system 100,
generated using a function generator and a set of pulse gen- 	 a processor 102, a display 106, a target 96, and an optional
erators. B-mode images were acquired sequentially from the 	 external trigger 108. HIFU transducer 94 and HIFU driving
EUB 6000 and were then processed offline using the software 55 system 104 are conventional, as generally known in the art,
program MATLAB (The Mathworks Inc., Natick, Mass.). 	 and need not be described in further detail. Significantly,
While the images were processed off-line in this study, the 	 ultrasound imaging probe 98 and ultrasound imaging system
results indicate that processing performed in real-time would	 100 require no modification, and can be implemented using
support the 11 frames per second frame rate noted above. 	 conventional, commercially available equipment. Target 96
In the above noted study, sequential ultrasound images 60 will generally be biological tissue (most often at a site in a
were acquired at a frame rate of 54 frames per second, with 	 human patient), although it should be recognized that the
the scanning window being swept across the imaging frame	 techniques described herein can be employed to enable a
(i.e., as shown in FIG. 413). A composite image, substantially	 composite interference-free ultrasound image to be generated
similar to that shown in FIG. 313, was created by combining 5	 from any target that could be imaged using conventional
overlapping imaging frames. The HIFU interference in the 65 ultrasound imaging. Display 106 can be implemented using a
composite image was negligible, and the full extent of the 	 conventional display and need not be described in greater
hyperechoic spot at the HIFU focus was clearly visible in the 	 detail. Processor 102 is preferably implemented using a com-
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puting device, such as a personal computer. It should be
recognized that it would be possible to implement processor
102 using a customized processor, or an application-specific
integrated circuit (ASIC). However, implementing processor
102 using a general processor computing machine instruc- 5
tions for carrying out the steps of FIG. 3A (e.g., software that
runs on a conventional personal computer) represents a par-
ticularly useful embodiment. Details of a preferred comput-
ing device are provided below.
As noted above, in one embodiment, both the ultrasound io
imaging system and the therapeutic ultrasound transducer are
triggered using external trigger 108 (the external trigger pref-
erably being implemented using a function generator and a
set of pulse generators). The external trigger can be controlled
such that the interference from the therapeutic ultrasound 15
transducer sweeps across the ultrasound imaging frames,
generally as indicated in FIG. 1B and FIG. 4B above. In
another embodiment, the ultrasound imaging system is trig-
gered independently, and the frequency of the square wave
used to induce a HIFU duty cycle is varied until the interfer- 20
ence from the HIFU sweeps across the ultrasound imaging
frames, generally as indicated in FIG. 1B and FIG. 413, as
discussed above.
FIG. 5B schematically illustrates an exemplary computing
system 150 suitable for use in implementing the method of 25
FIG. 3A (i.e., for executing the steps of this method). Exem-
plary computing system 150 includes a processing unit 154
that is functionally coupled to an input device 152 and to an
output device 162, e.g., a display (which can be display 106,
butmaybe any display forthe computing system). Processing 30
unit 154 comprises a central processing unit (CPU 158) that
executes machine instructions for carrying out a signal pro-
cessing program that processes a plurality of ultrasound
images to combine interference-free portions of those
images, generating a composite interference-free ultrasound 35
image. The machine instructions implement functions gener-
ally consistent with those described above with respect to
FIG. 3A, as well as those described below, with respect to
FIG. 6. CPUs suitable for this purpose are available, for
example, from Intel Corporation, AMD Corporation, 40
Motorola Corporation, and other sources, as will be well
known to those of ordinary skill in this art.
Also included in processing unit 154 are a random access
memory (RAM) 156 and non-volatile memory 160, which
can include read only memory (ROM) and may include some 45
form of memory storage, such as a hard drive, optical drive,
etc. These memory devices are bi-directionally coupled to
CPU 158. Such storage devices are well known in the art.
Machine instructions and data are temporarily loaded into
RAM 156 from non-volatile memory 160. Also stored in the 50
memory are an operating system software and ancillary soft-
ware. While not separately shown, it will be understood that
a generally conventional power supply will be included to
provide electrical power at a voltage and current level appro-
priate to energize computing system 150.	 55
Input device 152 can be any device or mechanism that
facilitates user input into the operating environment, includ-
ing, but not limited to, one or more of a mouse or other
pointing device, a keyboard, a microphone, a modem, or other
input device. In general, the input device will be used to 60
initially configure computing system 150, to achieve the
desired processing (i.e., to process a plurality of ultrasound
images to combine interference-free portions of those images
to generate a composite interference-free ultrasound image).
While not specifically shown in FIG. 513, it should be under- 65
stood that computing system 150 is logically coupled to ultra-
sound imaging system 100, HIFU driving system 104, dis-
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play 106, and external trigger 108 (when implemented).
Configuration of computing system 150 to achieve the
desired processing includes the steps of loading appropriate
processing software into non-volatile memory 160, and
launching the processing application (i.e., loading the pro-
cessing software into RAM 156) so that the processing appli-
cation is ready for use. Output device 162 generally includes
any device that produces output information, but will most
typically comprise a monitor or computer display designed
for human perception of output. Use of a conventional com-
puter keyboard for input device 152 and a computer display
for output device 162 should be considered as exemplary,
rather than as limiting on the scope of this present disclosure.
FIG. 6 is a more detailed flowchart 110 of the technique of
FIG. 3A for generating a composite interference-free ultra-
sound image when non-imaging ultrasound waves (such as
HIFU) are present. In a step 112, the HIFU cycle is adjusted
such that it is offset from the imaging cycle, generally as
described above with respect to FIG. 4B. In a step 114, an
ultrasound imaging system is used to obtain a plurality of
ultrasound image frames during HIFU therapy. In a step 116,
the signals used to produce raw ultrasound images including
both interference-free portions and interference are input to a
processor for processing. In a working prototype, the ultra-
sound images are acquired using, for example, the Video for
Windows feature in VideoOCXTM video capture software
(Marvelsoft of Berlin, Germany). VideoOCX TM provides
ActiveX controls that enable a user to grab frames from an
incoming video feed. Those of ordinary skill in the art will
recognize that many different image processing software
applications can be employed to capture a video feed, and the
use of VideoOCXTM is intended to be exemplary, rather than
limiting.
In a working prototype, the captured video frames were
copied to a clipboard using LabviewTM (National Instruments
Corp., Austin, Tex.) commands, one frame at a time. If HIFU
is not being applied, then the image is pasted from the clip-
board and any shapes that need to be drawn on the image
(such as ovals indicating projected lesion locations) are added
to produce a modified image, and the modified image is
displayed on the screen of the monitor or display. When the
HIFU transducer is turned on, however, large bands of inter-
ference appear in the ultrasound image. In order to visualize
the target location and apply treatment at the same time, a
duty cycle is applied to the HIFU signal, which produces a
window on the ultrasound image that is free of interference. A
square wave is used to induce the HIFU duty cycle. If the
frequency of the square wave is equal to the rate at which the
ultrasound probe's elements are interrogated, then the inter-
ference window remains stationary (see FIG. 413). As dis-
cussed above, in the present technique the frequency of the
square wave can be purposely offset relative to the ultrasound
imaging frequency, so that the window sweeps across the
ultrasound image. From each frame of video captured, the
processor acquires the portion that is free of interference.
Once the processor has acquired enough portions that are free
of interference to produce a complete image frame, it com-
bines them into one interference-free ultrasound image.
Referring once again to FIG. 6, the processing of the cap-
tured ultrasound images will now be described. In a step 118,
each raw ultrasound image (i.e., each frame) is split into
slices, generally as indicated in FIG. 7. Significantly, inter-
ference bands tend to originate at the bottom of ultrasound
images and fade as they progress upwards. In a decision step
120, each slice is analyzed to determine if the slice includes
interference, or if the slice is interference-free. The process
determines if a slice is free of interference by examining a
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predefined region of pixels that covers roughly the bottom
tenth of the slice. A mask is applied to the image that turns all
of the pixels but those within the region of interest black. The
progression of input image to slice, and then to the predefined
region, is shown in FIG. 7, with the masks appearing white in
the Figure to make the Figures easier to reproduce.
Statistical values are calculated for the pixel intensities
within the predefined region. The values are then used to
determine if the slice contains interference bands. Signifi-
cantly, pixels corresponding to interference can be readily
differentiated from pixels corresponding to an interference-
free portion of an ultrasound image. Pixels corresponding to
interference are characterized by having relatively high pixel
intensities, which are relatively consistent across the pre-
defined region. In contrast, pixels corresponding to an inter-
ference-free portion of an ultrasound image will generally
have lower intensifies, and will exhibit more variability
across the predefined region.
If this process determines that a slice is interference-free,
the slice is stored temporarily as indicated in a step 122. Once
a slice has been stored, no other slices representing the same
portion will be stored. In one embodiment, the ultrasound
imaging system stops interrogating the region corresponding
to a stored slice until an entire interference-free image is
obtained, as indicated in a step 124, and the algorithm starts
over, to generate the next composite interference-free ultra-
sound image. This approach prevents the same slice from
being incorporated into the composite altar sound image mul-
tiple times, which would produce inaccurately bright pixels.
In a decision step 126, the process determines if additional
slices are required to generate the interference-free composite
image. If so, another slice is selected, and the logic loops back
to decision step 120 to process the next slice. If in decision
step 120, it is determined that a slice is not interference-free,
the logic loops to decision step 126, to determine if additional
slices are required to complete the composite image. Once the
interference-free composite image is complete, it is displayed
as indicated in a step 128. Once the composite image is
complete, an additional step can be executed to determine if
any overlay shapes need to be incorporated into the composite
image. Some overlap may be noted between the slices used to
create the composite image. Overlapping portions are dis-
carded during image composition for the single composite
image frame.
As noted above, FIG. 7 schematically illustrates how the
slicing step of the FIG. 6 can be implemented. A raw ultra-
sound image frame 130 is selected and broken up into a
plurality of slices, as indicated by an exemplary slice 132.
Pixel intensities from a small portion 134 of the slice are
examined to determine if the slice is interference-free.
FIG. 8 is an image of an exemplary Lab View-based user
interface 136 that can be used to implement the method of
FIG. 3A (particularly in connection with the use of a phased
array transducer), and FIGS. 9A-9C are enlarged images of
selected portions of exemplary user interface 136. Major
functional elements are labeled with white text. Focal depth
assignment tools are used to define multiple foci, which are
displayed as ovals on the ultrasound-imaging monitor, in the
center of the interface. The HIFU duty cycle controls are used
to adjust the HIFU interference patterns that appear on the
ultrasound image. Treatment parameters are used to define
the applied electrical power and total treatment time. Soft-
ware controlling the interface was written to enable a user to
define a number of different focal depths along the transducer
axis, either by clicking directly on the ultrasound image in the
interface, or by entering a numeric value.
Referring to FIG. 9A, a HIFU properties portion 138 of
interface 136 enables the user to define a total power output
and duration for the HIFU treatment. The power setting is
programmed directly into ultrasound driving system 104 of
5 FIG. SA, which isin turn, connectedtoHIFUtransducer94of
FIG. 5A. The value entered for "Time" is used to determine
when to disable the driving system after it has been enabled
by a "GO!" button. A "Dosage" meter may also be set by the
user to automatically determine the power and time settings
io necessary to produce a desired dosage. Large (and preferably
red) "Stop Treatment' and "AbortAll"buttons are included in
case an error occurs with the hardware, or something goes
awry and the HIFU beam and lesions are being generated
outside of the desired treatment locations.
15 FIG. 9B shows a portion 140 of interface 136, which
enables a user to set a duty cycle of the HIFU beam, using the
slide control labeled "Interference Pattern." A "Left" button
and a "Right' button are included in case the user opts to
employ a function generator to produce a stationary interfer-
20 ence window. By manipulating the "Left" or "Right' button,
the user is able to move the ultrasound window to reveal
specific regions of the ultrasound image. On-screen pixels to
real-life millimeter ratios that correspond to each of the avail-
able imaging depths are preferably stored and available for
25 reference, as indicated by the drop down control labeled
"Imaging Depth."
Referring now to FIG. 9C, a portion 142 of interface 136
enables a user to control focal parameters of the HIFU beam.
The user has the option of defining several focal points auto-
30 matically, or setting each one independently. Clicking on
either of the "Point' buttons permits the assignment of one
focal point. A "Line" button produces a line of focal points
spaced 5 mm apart (such a dimension is intended to be exem-
plary, and not limiting). If the user selects a "With Mouse"
35 option, the user can click directly upon the ultrasound image
to assign the focal points. A "Numerical' option permits the
user to enter specific numerical values, either for the location
of a specific focal point or for the ends of a line of focal
depths. Regardless of the method that the user selects, the
40 interface will not accept any values outside a range of from
about 30 mm to about 60 mm, to ensure that all focal points
are within the focusing range of the HIFU transducer (again,
such dimensions are intended to be exemplary, and can vary
from one transducer to the next). After the user defines the
45 desired focal points, processor 102 determines the phase
delays required to drive the HIFU transducer (i.e., when using
a phased array transducer in an exemplary implementation) to
achieve treatment of the user-defined focal points. An `Auto
Step" control, when selected, divides a total treatment time
5o designated by the user into a plurality of equal durations (or
steps) for treatment of each defined focal point. If the `Auto
Step" control is not selected, the user can manually progress
through each focal point, controlling treatment time for each
individually, and terminating the process when all desired
55 sites have been treated.
FIG. 10A schematically illustrates a HIFU therapy probe
240 including a phased array transducer that canbe controlled
using user interface 136 of FIG. 8. HIFU therapy probe 240
includes a generally spoon shaped transducer 242 and a
6o handle 244. Transducer 242 is a phased array transducer
including 11 different transducer elements, six of which have
complete annuli, and five of which have truncated annuli.
Transducer 242 exhibits a focal range of about 3-6 cm.
FIG. 10B illustrates additional details of transducer 242,
65 clearly showing the plurality of different emitter elements
that are included therein. Generally spoon-shaped transducer
242 includes 11 discrete emitter elements, all equal in area,
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each element being separated from its neighbors by about 0.3
mm. Six of the emitter elements have complete annuli, and
five emitter elements have truncated annuli. The overall trans-
ducer dimensions are about 35 mmx60 mm. Generally spoon-
shaped transducer 242 has a center frequency of around 3 5
MHz, a focal length of about 3-6 cm, a geometric focus of
about 5 cm, and a maximum focal intensity of about 3000
W/cm2.
An empirical device implemented transducer 242 with a
3-MHz, 11-element 1-3 composite annular array (Imasonic, 10
Besancon, France), with a matching layer formed from epoxy
resin. The natural focus of the array was at 50 mm. Eleven
elements were chosen due to economic, ergonomic, and driv-
ing hardware constraints. The transducer is elliptically
shaped with a length of 60 mm, a width of 35 mm, and a depth 15
of 75 mm, to facilitate transvaginal placement. In an empiri-
cal study, the HIFU transducer was connected in series with a
custom-built matching network (to match the impedance to
50Q) and a multi-channel ultrasound driving system (Ad-
vanced Surgical Systems, Inc, Tuscon, Ariz.). Eleven ampli- 20
fier channels were used to drive the array. The driving system
was controlled using software written in the LabView pro-
gramming environment (see user interface 136 of FIG. 8). To
display the ultrasound image on the computer screen (FIGS.
8 and 9C), a video capture device (Dazzle 80, Pinnacle Sys- 25
tems, Mountain View, Calif.) was used to capture the video
signal from the ultrasound imaging unit. The video data was
then imported into the LabView program using ActiveX con-
trols (VideoOCX, Marvelsoft, Berlin, Germany, generally as
described above). Processing, generally as described above, 30
is used to generate a composite interference-free image.
The computer communicates with the driving system via
an RS-232 connection. The user interface of FIG. 8 is
designed to enable the user to individually define an unlimited
number of focal depths along the transducer axis, either by 35
clicking directly on the ultrasound image or by typing in the
numerical value (see FIG. 9C). In addition, a row of lesions
spaced 5 mm apart could be set by designating the start and
end of the line within the 30 to 60 mm range. Based on the
assumption of constant speed of sound throughout the acous- 40
tic path (1500 m/s), the computer (i.e., processor 102, FIG.
5A) calculates the necessary phase delays for each focus. The
values are then automatically programmed into the ultra-
sound driving system using serial commands provided by the
manufacturer. In addition to the phase and power settings of 45
each channel, RS-232 serial port commands were used to
initiate and terminate ultrasound emission, as well as to
enable a shift between focal depths. The total incident elec-
trical power sent to the array was constrained to a range of 0
to 165 W, the latter of which was determined by the manu- 50
facturer to be the highest acceptable value for the transducer.
Although the present invention has been described in con-
nection with the preferred form of practicing it and modifi-
cations thereto, those of ordinary skill in the art will under-
stand that many other modifications can be made to the 55
present invention within the scope of the claims that follow.
Accordingly, it is not intended that the scope of the invention
in any way be limited by the above description, but instead be
determined entirely by reference to the claims that follow.
60
The invention in which an exclusive right is claimed is
defined by the following:
1. A method for producing a composite interference-free
ultrasound image when non-imaging ultrasound waves 65
would otherwise interfere with ultrasound imaging, compris-
ing the steps of:
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(a) providing a plurality of ultrasound image frames that
were produced in the presence of non-imaging ultra-
sound waves;
(b) automatically analyzing the plurality of ultrasound
image frames to identify interference-free portions of
the ultrasound image frames wherein the step of auto-
matically analyzing the plurality of ultrasound image
frames to identify interference-free portions comprises
the steps of:
(i) separating an ultrasound image frame into a plurality
of slices;
(ii) for each slice, selecting a predefined portion of the
slice;
(iii) calculating statistical values for pixel intensities in
the predefined portion; and
(iv) based on the statistical values, determining if the
predefined portion corresponds to interference, such
that if the predefined portion does not correspond to
interference the slice is temporarily stored, and if the
predefined portion does correspond to interference,
discarding the slice; and
(c) automatically combining a plurality of interference-
free portions to generate the composite interference-free
ultrasound image.
2. The method of claim 1, further comprising the step of
displaying the composite interference-free ultrasound image.
3. The method of claim 1, wherein the step of providing the
plurality of ultrasound image frames that were produced in
the presence of non-imaging ultrasound waves comprises the
step of providing a plurality of ultrasound image frames pro-
duced during HIFU therapy.
4. The method of claim 3, wherein the step of providing a
plurality of ultrasound image frames produced during HIFU
therapy comprises the step of ensuring that a frequency of the
HIFU therapy is offset from a frequency of imaging waves
used to produce the plurality of ultrasound image frames, so
that interference due to the HIFU therapy does not appear in
the same place in each of the plurality of frames.
5. The method of claim 4, wherein a difference between the
frequency of the HIFU therapy and the frequency of imaging
waves used to generate the plurality of ultrasound image
frames is sufficiently great to enable a frame rate of the
composite interference-free ultrasound image to support a
relatively stable display.
6. The method of claim 5, wherein the frame rate of the
composite interference-free ultrasound image is greater than
about eight frames per second.
7. The method of claim 3, further comprising the step of
offsetting the frequency of a square wave used to control the
HIFU therapy relative to a frequency of imaging waves used
to generate the plurality of ultrasound image frames, so that
interference due to the HIFU therapy does not appear in the
same place in each of the plurality of ultrasound image
frames.
8. The method of claim 1, further comprising the step of
directing a signal corresponding to each of the plurality of
ultrasound image frames to a computing device for process-
ing to generate the composite interference-free ultrasound
image.
9. The method of claim 1, wherein the step of combining
the plurality of interference-free portions to generate a com-
posite frame comprises the step of combining stored slices
until the interference-free ultrasound image is achieved.
10. The method of claim 1, further comprising the step of
discarding additional slices corresponding to a stored slice, to
prevent the composite interference-free ultrasound image
from including inaccurately bright pixels.
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11. The method of claim 1, wherein the step of selecting the
predefined portion from the slice comprises the step of select-
ing a bottom portion of the slice.
12. The method of claim 1, further comprising the step of
determining if an overlay is to be incorporated into the com-
posite interference-free ultrasound image, and if so, incorpo-
rating the overlay into the composite interference-free ultra-
sound image.
13. The method of claim 1, further comprising the step of
restricting a scanning window associated with an ultrasound
imaging system used to produce the plurality of ultrasound
image frames to a defined limited portion of an ultrasound
image frame, to increase a frame rate at which the composite
interference-free ultrasound image is generated.
14. A memory medium on which are stored machine
instructions employed for carrying out a plurality of steps,
wherein the plurality of steps include:
(a) capturing a plurality of ultrasound image frames
acquired in the presence of non-imaging ultrasound
waves;
(b) automatically analyzing the ultrasound image frames to
identify interference-free portions of the ultrasound
image frames by:
(i) separating an ultrasound image frame into a plurality
of slices;
(ii) for each slice, selecting a predefined portion of the
slice;
(iii) calculating statistical values for pixel intensities in
the predefined portion; and
(iv) based on the statistical values, determining if the
predefined portion corresponds to interference, such
that if the predefined portion does not correspond to
interference, the slice is temporarily stored, and if the
predefined portion does correspond to interference,
discarding the slice; and
(c) automatically combining a plurality of interference-
free portions to generate a composite interference-free
ultrasound image.
15. The memory media of claim 14, wherein the machine
instructions are further employed for carrying out the step of
displaying the composite interference-free ultrasound image.
16. The memory media of claim 14, wherein the machine
instructions are further employed for carrying out the step of
enabling a user to select a frequency of the non-imaging
ultrasound waves, such that the selected frequency is different
than a frequency of ultrasound imaging waves used to acquire
the plurality of ultrasound image frames, thereby ensuring
18
that interference in the plurality of ultrasound image frames
due to the non-imaging ultrasound waves does not appear in
the same position in each ultrasound image frame.
17. The memory media of claim 14, wherein the machine
5 instructions are further employed for carrying out the step of
combining stored slices until the interference-free ultrasound
image is achieved.
18. The memory media of claim 14, wherein the machine
instructions are further employed for carrying out the step of
io discarding additional slices corresponding to a stored slice, to
prevent the composite interference-free ultrasound image
from including inaccurately bright pixels.
19. The memory media of claim 14, wherein the machine
instructions are further employed for carrying out the step of
15 selecting the predefined portion from a bottom of the slice.
20. A system for obtaining a composite interference-free
ultrasound image when non-imaging ultrasound waves
would otherwise interfere with ultrasound imaging, compris-
ing:
20	 (a) an ultrasound imaging system configured to generate a
plurality of ultrasound image frames; and
(b) a processor logically coupled to the ultrasound imaging
system and configured to implement a plurality of func-
tions, including:
25 (i) capturing a plurality of ultrasound image frames
acquired in the presence of non-imaging ultrasound
waves;
(ii) automatically analyzing the ultrasound image
frames to identify interference-free portions of the
30	 ultrasound image frames by:
(A) separating an ultrasound image frame into a plu-
rality of slices;
(B)for each slice, selecting a predefined portion of the
slice;
35	 (C) calculating statistical values for pixel intensities
in the predefined portion; and
(D) based on the statistical values, determining if the
predefined portion corresponds to interference,
such that if the predefined portion does not corre-
40 spond to interference, the slice is temporarily
stored, and if the predefined portion does corre-
spond to interference, discarding the slice; and
(iii) automatically combining the interference-free por-
tions to generate a composite interference-free ultra-
45	 sound image.
